title: Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.
authors.forename: Su-Mi
authors.initials: SM
authors.lastname: Choi
authors.forename: Dong-Gun
authors.initials: DG
authors.lastname: Lee
authors.forename: Jung-Hyun
authors.initials: JH
authors.lastname: Choi
authors.forename: Jin-Hong
authors.initials: JH
authors.lastname: Yoo
authors.forename: Yoo-Jin
authors.initials: YJ
authors.lastname: Kim
authors.forename: Sun Hee
authors.initials: SH
authors.lastname: Park
authors.forename: Chang-Ki
authors.initials: CK
authors.lastname: Min
authors.forename: Seok
authors.initials: S
authors.lastname: Lee
authors.forename: Hee-Je
authors.initials: HJ
authors.lastname: Kim
authors.forename: Dong-Wook
authors.initials: DW
authors.lastname: Kim
authors.forename: Jong-Wook
authors.initials: JW
authors.lastname: Lee
authors.forename: Woo-Sung
authors.initials: WS
authors.lastname: Min
authors.forename: Wan-Shik
authors.initials: WS
authors.lastname: Shin
authors.forename: Chun-Choo
authors.initials: CC
authors.lastname: Kim
mesh_terms: D000961:Antilymphocyte Serum / Q000008:administration & dosage; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D046148:Donor Selection; D005260:Female; D006801:Humans; D015994:Incidence; D007723:Korea; D019520:Living Donors; D008297:Male; D008991:Monitoring, Physiologic; D011446:Prospective Studies; D012307:Risk Factors; D033581:Stem Cell Transplantation / Q000009:adverse effects; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum